{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:18Z","timestamp":1762004778552},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143940","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T19:04:30Z","timestamp":1449083070000},"page":"e0143940","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up"],"prefix":"10.1371","volume":"10","author":[{"given":"Kirsten","family":"Korsholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Granqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liselotte","family":"H\u00f8jgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aase K.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,2]]},"reference":[{"issue":"21","key":"ref1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry&apos;s disease. Ceramidetrihexosidase deficiency","volume":"276","author":"RO Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"DP Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry&apos;s disease","volume":"345","author":"CM Eng","year":"2001","journal-title":"N Engl J Med"},{"issue":"21","key":"ref4","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"R Schiffmann","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/01.wnl.0000338566.54190.8a","article-title":"Diagnostic utility of different MRI and MR angiography measures in Fabry disease","volume":"72","author":"AM Fellgiebel","year":"2009","journal-title":"Neurology"},{"key":"ref6","article-title":"Fabry disease and early stroke","author":"U Feldt-Rasmussen","year":"2011","journal-title":"Stroke Res Treat"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry&apos;s disease","volume":"40","author":"P Mitsias","year":"1996","journal-title":"Ann Neurol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"KE Crutchfield","year":"1998","journal-title":"Neurology"},{"issue":"1\u20132","key":"ref9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","article-title":"The cerebral vasculopathy of Fabry disease","volume":"257","author":"DF Moore","year":"2007","journal-title":"J Neurol Sci"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"T DeGraba","year":"2000","journal-title":"Ann Neurol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"R Schiffmann","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1085-9489.2006.00076.x","article-title":"Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin","volume":"11","author":"AT Moller","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/GIM.0b013e31815cb197","article-title":"Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density","volume":"9","author":"H Mersebach","year":"2007","journal-title":"Genet Med"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ndt\/gft452","article-title":"Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease","volume":"29","author":"T Prabakaran","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1109\/23.531882","article-title":"Investigation of the performance of the General Electric ADVANCE positron emission tomograph in 3D mode","volume":"43","author":"TK Lewellen","year":"1996","journal-title":"Nuclear Science, IEEE Transactions on"},{"issue":"7","key":"ref16","first-page":"1238","article-title":"A diagnostic approach in Alzheimer&apos;s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"S Minoshima","year":"1995","journal-title":"J Nucl Med"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer&apos;s dementia and normal aging","volume":"149","author":"F Fazekas","year":"1987","journal-title":"Am J Roentgenol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"LO Wahlund","year":"2001","journal-title":"Stroke"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.53.1.132","article-title":"MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study","volume":"53","author":"R Schmidt","year":"1999","journal-title":"Neurology"},{"issue":"1\u20132","key":"ref20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2007.01.018","article-title":"Progression of cerebral white matter lesions\u2014clinical and radiological considerations","volume":"257","author":"C Enzinger","year":"2007","journal-title":"J Neurol Sci"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","article-title":"White matter lesions in Fabry disease occur in &apos;prior&apos; selectively hypometabolic and hyperperfused brain regions","volume":"62","author":"DF Moore","year":"2003","journal-title":"Brain Res Bull"},{"issue":"5","key":"ref22","first-page":"737","article-title":"18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis","volume":"40","author":"A Drzezga","year":"1999","journal-title":"J Nucl Med"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"DF Moore","year":"2001","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2377-2-4","article-title":"Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease","volume":"2","author":"DF Moore","year":"2002","journal-title":"BMC Neurol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/01.wnl.0000173030.70057.eb","article-title":"White matter lesion severity in male and female patients with Fabry disease","volume":"65","author":"AM Fellgiebel","year":"2005","journal-title":"Neurology"},{"issue":"1\u20132","key":"ref26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.03.020","article-title":"Brain MRI findings in patients with Fabry disease","volume":"305","author":"RC Reisin","year":"2011","journal-title":"J Neurol Sci"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00415-006-0118-y","article-title":"Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study","volume":"253","author":"A Fellgiebel","year":"2006","journal-title":"J Neurol"},{"issue":"6","key":"ref28","first-page":"1096","article-title":"Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease","volume":"24","author":"DF Moore","year":"2003","journal-title":"Am J Neuroradiol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00415-008-0786-x","article-title":"The pulvinar sign: frequency and clinical correlations in Fabry disease","volume":"255","author":"A Burlina","year":"2008","journal-title":"Journal of Neurology"},{"issue":"447","key":"ref30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/08035320510028076","article-title":"Natural history of the cerebrovascular complications of Fabry disease","volume":"94","author":"A Mehta","year":"2005","journal-title":"Acta Paediatr Suppl"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1161\/STROKEAHA.109.548222","article-title":"Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study","volume":"40","author":"JF Buyck","year":"2009","journal-title":"Stroke"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:00:45Z","timestamp":1540346445000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143940"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,2]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143940","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,2]]}}}